Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04278755 · ClinicalTrials.gov registry record · Phase 2
Binge Eating & Birth Control
A Phase 2 study, sponsored by University of North Carolina, Chapel Hill.
- Terminated
- Registry status
- Phase 2
- Development phase
- 8
- Enrollment target
NCT04278755 is a Phase 2 study that was terminated before completion, run by University of North Carolina, Chapel Hill. The registered enrollment target is 8 participants.
The verdict
NCT04278755, a Phase 2 study, was terminated before completion, sponsored by University of North Carolina, Chapel Hill.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 8 participants
- Enrollment target
Study Summary
This pilot study examines the effect of stabilizing ovarian hormones on eating behaviors and brain activation in women with binge eating (n=15) using functional magnetic resonance imaging (fMRI) and behavioral tests. This is completed by taking oral contraceptives (birth control) continuously for three months. Prior to medication administration and at the end of treatment, eating behaviors will be measured and fMRI will be conducted in order to examine changes in activation in dopamine-reward pathways that occur with oral contraceptive administration. This will assess changes in brain activation that occur with the stabilization of ovarian hormones.
Interventions
- DRUG Drospirenone-Ethinyl Estradiol Oral Tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2020-09-24 |
| Est. Completion | 2022-05-17 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04278755
The ClinicalTrials.gov registry entry for NCT04278755 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Drospirenone-Ethinyl Estradiol Oral Tablet is the first listed.
NCT04278755 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04278755 about?
NCT04278755 is a clinical study titled "Binge Eating & Birth Control". This pilot study examines the effect of stabilizing ovarian hormones on eating behaviors and brain activation in women with binge eating (n=15) using functional magnetic resonance imaging (fMRI) and behavioral tests. This is completed by taking oral contraceptives (birth control) continuously for th...
What is the current status of trial NCT04278755?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 8 participants. The study started on 2020-09-24. Estimated completion is 2022-05-17.
What interventions are being tested in trial NCT04278755?
The interventions under investigation include: Drospirenone-Ethinyl Estradiol Oral Tablet (DRUG).
Who is sponsoring clinical trial NCT04278755?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.